文献速递炎症性肠病消化内镜

磁共振小肠造影对克罗恩病患者小肠内镜愈合的效用

Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
PubMed 文献 · Am J Gastroenterol · 2017-12-19

本研究前瞻性随访139例临床-血清学缓解的克罗恩病患者,比较磁共振小肠造影(MRE)与气囊辅助小肠镜(BAE)评估小肠病变。小肠内镜愈合(SES-CDa<5)见于76例(54.7%);缺乏小肠内镜愈合是临床复发(HR 5.34)和血清学复发(HR 3.02)的独立危险因素;MRE溃疡愈合(MaRIA评分<11)诊断内镜愈合的准确率为90.9%。

要点

  • 临床-血清学缓解的克罗恩病患者中,小肠内镜未愈合是临床和血清学复发的独立危险因素。
  • MRE溃疡愈合(MaRIA评分<11)对判断小肠内镜愈合具有高诊断准确率(90.9%)。
  • MRE在纵向反应性上与BAE的一致性kappa系数为0.754(临床复发)和0.783(血清学复发)。

核心结论

  • 小肠炎症与临床-血清学缓解的克罗恩病患者的不良预后相关。
  • MRE是评估小肠炎症活动的有效且可靠的检查,可用于横断面评估和预后预测。

研究设计与样本

  • 前瞻性随访研究,共纳入139例处于临床-血清学缓解的克罗恩病患者,在BAE和MRE检查后随访。
  • 采用改良版克罗恩病简单内镜评分(SES-CD)评估小肠,称为克罗恩病简单内镜活动评分(SES-CDa);MR评估采用磁共振活动指数(MaRIA)。
  • 主要终点为至临床复发时间(CD活动指数>150且较基线增加>70分)和至血清学复发时间(C反应蛋白异常升高)。

主要发现

  • 临床复发发生于30例(21.6%)患者,血清学复发发生于62例(44.6%)患者。
  • 小肠内镜愈合(SES-CDa<5)见于76例(54.7%)患者。
  • 多因素回归分析显示,缺乏小肠内镜愈合是临床复发的独立危险因素(HR 5.34;95%CI 2.06-13.81),也是血清学复发的独立危险因素(HR 3.02;95%CI 1.65-5.51)。
  • MRE溃疡愈合(MaRIA评分<11)诊断内镜愈合的准确率为90.9%(95%CI 87.9-93.2%)。
  • BAE与MRE在纵向反应性上的kappa系数:临床复发为0.754(95%CI 0.658-0.850),血清学复发为0.783(95%CI 0.701-0.865)。

关键数值与推荐

  • 小肠内镜愈合定义为SES-CDa<5。
  • MRE溃疡愈合定义为MaRIA评分<11。
  • 临床复发定义为CD活动指数>150且较基线增加>70分。
  • 血清学复发定义为C反应蛋白异常升高。

临床怎么用

  • MRE是评估小肠炎症活动的有效且可靠的检查,可用于横断面评估和预后预测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Small bowel (SB) endoscopic healing has not been well studied in patients with Crohn's disease (CD). This study aims to evaluate the utility of magnetic resonance (MR) enterography (MRE) for SB lesions in comparison with balloon-assisted enteroscopy (BAE) findings. METHODS: In total, 139 patients with CD in clinical-serological remission were prospectively followed after BAE and MRE procedures. We applied a modified version of the Simple Endoscopic Score for CD (SES-CD) for an endoscopic evaluation of the SB, called the Simple Endoscopic Active Score for CD (SES-CDa). We also used the MR index of activity (MaRIA) for MR evaluations. The primary end points were time to clinical relapse (CD activity index of >150 with an increase of >70 points) and serological relapse (abnormal elevation of C-reactive protein). RESULTS: Clinical and serological relapses occurred in 30 (21.6%) and 62 (44.6%) patients, respectively. SB endoscopic healing (SES-CDa<5) was observed in 76 (54.7%) patients. A multiple regression analysis showed that the lack of SB endoscopic healing was an independent risk factor for clinical relapses (hazard ratio (HR): 5.34; 95% confidence interval (CI): 2.06-13.81) and serological relapses (HR: 3.02; 95% CI: 1.65-5.51), respectively. MR ulcer healing (MaRIA score <11) demonstrated a high diagnostic accuracy (90.9%; 95% CI: 87.9-93.2%) for endoscopic healing. The kappa coefficient between BAE and MRE for longitudinal responsiveness was 0.754 (95% CI: 0.658-0.850) for clinical relapse and 0.783 (95% CI: 0.701-0.865) for serological relapse. CONCLUSIONS: SB inflammation was associated with a poor prognosis in patients with clinical-serological remission. MRE is a valid and reliable examination for SB inflammatory activity both for cross-sectional evaluations and prognostic prediction.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Takenaka K, Ohtsuka K, Kitazume Y, et al. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease. Am J Gastroenterol. 2017. PMID: 29257147. doi:10.1038/ajg.2017.464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。